Alumis (ALMS) Research & Development (2023 - 2025)
Alumis (ALMS) reported Research & Development of $82.8 million for Q4 2025, down 5.07% year-over-year from $87.2 million in Q4 2024, and down 15.38% quarter-over-quarter from $97.8 million in Q3 2025.
Alumis (ALMS) Research & Development (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Research & Development data on file, last reported at $82.8 million in Q4 2025.
- Research & Development for Q4 2025 came in at $82.8 million, down 5.07% year-over-year; the trailing twelve-month figure through Dec 2025 was $386.0 million (up 45.36% YoY), and the FY2025 annual result was $386.0 million, up 45.36% from the prior year.
- Research & Development slipped to $82.8 million in Q4 2025 per ALMS's latest filing, from $97.8 million in the prior quarter.
- Over five years, Research & Development peaked at $108.8 million in Q2 2025 and troughed at $32.8 million in Q2 2023.
- A 3-year average of $68.8 million and a median of $82.8 million in 2025 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2025: Research & Development surged 152.0% in 2024, then declined 5.07% in 2025.
- A 3-year view of Research & Development shows it stood at $34.6 million in 2023, then soared by 152.0% to $87.2 million in 2024, then decreased by 5.07% to $82.8 million in 2025.
- Business Quant data shows ALMS's Research & Development at $82.8 million in Q4 2025, $97.8 million in Q3 2025, and $108.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 82.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82.79 Mn |
| Sep 30, 2025 | 97.84 Mn |
| Jun 30, 2025 | 108.76 Mn |
| Mar 31, 2025 | 96.62 Mn |
| Dec 31, 2024 | 87.20 Mn |
| Sep 30, 2024 | 87.82 Mn |
| Jun 30, 2024 | 48.57 Mn |
| Mar 31, 2024 | 41.96 Mn |
| Dec 31, 2023 | 34.61 Mn |
| Sep 30, 2023 | 37.79 Mn |
| Jun 30, 2023 | 32.85 Mn |